Smoking Cessation Clinical Trials

60 studies are recruiting for smoking cessation in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 3

1. Tobacco Education and Lung Health Study (TEAL)

   Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach…

   Stage

   Phase 3

   Ages

   50 to 80

   Site

   Georgetown University Medical Center, Washington D.C., District of Columbia

   Run by

   Georgetown University

   See if you can join NCT06290869 on ClinicalTrials.gov

2. Take A Break - Rural

   The study team proposes a multi-level trial to test 1) novel implementation programs in rural counties designed to increase access to 2) recent advances in tobacco control services for people who are not-yet-ready-to-quit smoking. In this field, most trials have focused only on those already ready-…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Wake Forest University Health Sciences, Winston-Salem, North Carolina

   Run by

   Wake Forest University Health Sciences

   See if you can join NCT05790486 on ClinicalTrials.gov

3. Veteran Social Support for Enhancing Use of Smoking Cessation Treatment

   This study is recruiting Veterans who currently smoke cigarettes and support persons who are nominated by the Veterans. The purpose of this study is to assist Veterans with smoking cessation by asking Veterans to choose a support person who will assist them with the quitting process, or who may ass…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis, Minnesota

   Run by

   VA Office of Research and Development

   See if you can join NCT05868421 on ClinicalTrials.gov

4. Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity

   This study will randomize 64 non-treatment seeking individuals who smoke cigarettes daily in a double-blind, placebo-controlled laboratory study testing the effects of cytisinicline on the neural substrates of cigarette cue reactivity.

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   University of California Los Angeles, Los Angeles, California

   Run by

   University of California, Los Angeles

   See if you can join NCT06617312 on ClinicalTrials.gov

5. Technology Assisted Motivational Interviewing

   Building on our successful pilot work to develop a Motivational Interviewing (MI)-capable chatbot and cessation coach, the investigators propose to address the problems of intrinsic motivation and social barriers to smoking cessation by evaluating a highly scalable and easily accessible digital-coa…

   Stage

   Not phased

   Ages

   18 and older

   Site

   San Francisco General Hospital, San Francisco, California

   Locations

   2 in total

   Run by

   University of California, San Francisco

   See if you can join NCT06713603 on ClinicalTrials.gov

6. Wellness Intervention for Smoking and HIV

   The investigators propose to use a parallel group, randomized controlled trial to test the efficacy of a 13-week personalized approach to reducing smoking intervention versus a second approach using a different health intervention on smoking cessation, healthy sleep metrics, and biomarkers of cardi…

   Stage

   Not phased

   Ages

   18 to 75

   Site

   Banner University Medical Center Phoenix, Phoenix, Arizona

   Locations

   2 in total

   Run by

   University of Arizona

   See if you can join NCT04725617 on ClinicalTrials.gov

7. Healing Within: Mindfulness Smoking Cessation Intervention

   Using a highly participatory approach, this study will assess the feasibility, acceptability, and satisfaction with a culturally tailored, trauma-informed smoking cessation intervention for Northern Plains Tribal women who have experienced intimate partner violence. If successful, other American In…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Black Hills Center for American Indian Health, Rapid City, South Dakota

   Run by

   National Heart, Lung, and Blood Institute (NHLBI)

   See if you can join NCT07013968 on ClinicalTrials.gov

8. V+PSF-M for Tobacco Cessation in HIV Care in India

   The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apova…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   University of Colorado, Aurora, Colorado

   Locations

   2 in total

   Run by

   University of Colorado, Denver

   See if you can join NCT05786547 on ClinicalTrials.gov

9. New Strategies to Enhance Smoking Cessation

   The study goal is to get feedback on ways researchers can communicate complex research findings on smoking cessation to better inform patients' decisions to use medication and/or quit smoking. This will help researchers and clinicians to provide effective, easy-to-implement treatments designed to a…

   Stage

   Not phased

   Ages

   18 to 75

   Site

   University of Chicago, Chicago, Illinois

   Run by

   University of Chicago

   See if you can join NCT06751927 on ClinicalTrials.gov

10. Remote Smoking Cessation in Hospitalized Cardiac Patients

    The investigators are proposing to examine new strategies for helping patients hospitalized for an acute coronary event adhere to recommendations to quit smoking. The investigators are interested to see whether offering financial incentives for smoking cessation, combined with medications to amelio…

    Stage

    Not phased

    Ages

    18 and older

    Site

    University of Vermont Medical Center, Burlington, Vermont

    Run by

    University of Vermont Medical Center

    See if you can join NCT05738408 on ClinicalTrials.gov